sulfadiazine is an approved drug (FDA (1941), UK (2008))
Compound class:
Synthetic organic
Comment: Sulfadiazine is a sulfonamide with broad-spectrum antimicrobial activity [4]. It is used in the treatment of toxoplasmosis, an infection with the protozoan parasite Toxoplasma gondi that can cause serious complications during pregnancy and in patients with weakened immune systems. Dermatological formulations containing silver sulfadiazine (PubChem CID 441244) are used to prevent and treat wound infections.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1941), UK (2008)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
IUPAC Name |
4-amino-N-pyrimidin-2-ylbenzenesulfonamide |
International Nonproprietary Names | |
INN number | INN |
421 | sulfadiazine |
Database Links | |
Specialist databases | |
Antibiotic DB | Sulfadiazine, silver sulfadiazine (salt of sulphadiazine) |
Other databases | |
CAS Registry No. | 68-35-9 (source: Scifinder) |
ChEBI | CHEBI:9328 |
ChEMBL Ligand | CHEMBL439 |
DrugBank Ligand | DB00359 |
DrugCentral Ligand | 2500 |
GtoPdb PubChem SID | 479821425 |
PubChem CID | 5215 |
Search Google for chemical match using the InChIKey | SEEPANYCNGTZFQ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | SEEPANYCNGTZFQ |
Search PubMed clinical trials | sulfadiazine |
Search PubMed titles | sulfadiazine |
Search PubMed titles/abstracts | sulfadiazine |
UniChem Compound Search for chemical match using the InChIKey | SEEPANYCNGTZFQ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SEEPANYCNGTZFQ-UHFFFAOYSA-N |
Wikipedia | Sulfadiazine |